What do I need to know about the new RSV vaccine?
Researchers have been working on a vaccine for respiratory syncytial virus, or RSV, for decades. This week, the first ever RSV vaccine was approved by the U.S. Food and Drug Administration. We speak about that and other potential RSV treatments with Sabina Vohra-Miller, founder of the website Unambiguous Science. For transcripts of this series, please visit: https://www.cbc.ca/radio/podcastnews/the-dose-transcripts-listen-1.6732281
The Dose · CBC
May 10, 202323m 18s
Audio is streamed directly from the publisher (mgln.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Researchers have been working on a vaccine for respiratory syncytial virus, or RSV, for decades. This week, the first ever RSV vaccine was approved by the U.S. Food and Drug Administration. We speak about that and other potential RSV treatments with Sabina Vohra-Miller, founder of the website Unambiguous Science.
For transcripts of this series, please visit: https://www.cbc.ca/radio/podcastnews/the-dose-transcripts-listen-1.6732281